COHANCE — Cohance Lifesciences Share News
0.000.00%
Last trade - 00:00- IN₹172.11bn
- IN₹174.06bn
- IN₹22.69bn
India's Cohance Lifesciences set for worst day in 3 yrs on lower Q1 profit
Brief: Cohance Lifesciences June-Quarter Net Profit 525.7 Million Rupees
Brief: Cohance Lifesciences To Sell CR Bio Unit For 160 Mln Rupees
India's Cohance Lifesciences drops on quarterly profit fall
Brief: Suven Pharmaceuticals To Issue 11 Co Shares For Every 295 Cohance Lifesciences Shares
India's Suven Pharma gains; Goldman Sachs starts with 'buy'
India's Suven Pharma soars on Q3 profit surge
Brief: Suven Pharmaceuticals Says Casper Pharma Dissolved And Amalgamated With Co
Brief: Suven Pharmaceuticals Says Vaidheesh Annaswamy Decided To Step Down As Executive Chairperson
Brief: Suven Pharmaceuticals June-Quarter Consol Net Profit 607.7 Mln Rupees
India's Suven Pharma rises after $28 mln acquisition
Brief: Suven Pharmaceuticals Executed Definitive Agreements For Acquiring 100% Of Shares In Sapala Organics
India's Suven Pharma hits over 2-month low after qtrly profit falls
India's Suven Pharma surges on plans to merge with privately held Cohance
India's Suven Pharma, Cohance merge to boost contract drug manufacturing services
Brief: Suven Pharmaceuticals Approved Scheme Of Amalgamation Of Cohance Lifesciences Into And With Co
Brief: Suven Pharmaceuticals Says Shareholders Of Cohance Will Be Issued Shares Of Co At Ratio Of 11 Shares Of Co For Every 295 Shares Of Cohance
India's Suven Pharma up as US FDA completes inspections without observations
Brief: Suven Pharmaceuticals Says Pre-Approval Inspections And Good Manufacturing Practices Inspections By USFDA Completes